Interdependent Treatment

MOA is an emerging innovation in the treatment of many disease states; including allergy, respiratory and systemic interdependence of localized inflammatory, spastic, and/or hypoxic conditions.

Variability & Optionality

MOA addresses the opportunity for the patient to tailor their application to the orifice of choice based on certain restrictions within a single maxillofacial orifice (obstruction, pain, infection, degradation).

Customizable Dosing Application

This new age approach to customizing orifice application is tailored to patience specific presentation of system interdependencies, restrictions, pathological chain reactions, and symptom correlations. 

Emerging Treatment Frontier in a First-In-Class Medical Device

MOA-21 addresses the opportunity for patients and their practitioners to optimize therapy by targeting a synchronous multiple maxillofacial orifice therapy, intended to apply pharmaceutical or nutraceutical active therapeutics. This essentially treats systemic and chain reactive correlations in synergy and potentially provides enhanced patient outcomes with physiologically objective and symptomology subjective outcomes.